XML 20 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Mar. 31, 2017
Mar. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income (loss) $ (4,944,186) $ 3,757,957
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:    
Gain on sale of marketable securities (576,162) (49,720)
Loss (gain) on sale of property and equipment 25,470 (5,968)
Change in inventory reserves 2,188,192 (945,354)
Change in accounts receivable reserves 194,286 482,915
Depreciation, amortization and impairment 3,181,845 1,257,207
Change in cash surrender value of life insurance (151,393) (109,386)
Deferred income taxes (659,000) 90,484
Warranty reserve (15,173) 140,768
Other-than-temporary impairment loss on investments 2,755,318
Compensation expense related to stock options 29,334
Change in operating assets and liabilities:    
Accounts receivable (5,524,446) (1,530,289)
Notes receivable and other non-trade receivables (1,600,290) 119,889
Inventories (7,845,801) (877,993)
Prepaid expenses and other assets (129,532) (422,547)
Accounts payable 4,146,921 605,940
Accrued expenses 1,618,100 1,217,786
Income taxes payable/ receivable 306,900 (524,900)
Non-current liabilities (525,143) (21,606)
Total adjustments (2,609,908) (543,440)
Net cash (used in) provided by operating activities (7,554,094) 3,214,517
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of marketable securities (2,719,369) (4,481,030)
Proceeds from sale of marketable securities 6,002,601 226,759
Business combinations, net of cash acquired (4,573,700) 78,000
Capital expenditures (2,346,431) (1,246,071)
Proceeds from sale of property and equipment 6,281 200,634
Increase in restricted cash (69,718) (44,298)
Net cash used in investing activities (3,700,336) (5,266,006)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from line of credit 68,275,140 14,296,108
Payments on line of credit (49,805,658) (19,302,273)
Stock repurchase (7,917,009)
Proceeds from funding of lease 7,428
Net cash provided by (used in) financing activities 8,688,338 (5,993,746)
Effect of foreign currency exchange rates on cash and cash equivalents (15,998) 1,923
NET DECREASE IN CASH AND CASH EQUIVALENTS (2,582,090) (8,043,312)
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR 5,345,455 13,388,767
CASH AND CASH EQUIVALENTS AT END OF YEAR 2,763,365 5,345,455
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING ACTIVITIES:    
Finished goods inventory transferred to equipment leased to customers 272,622 1,288,474
Non-controlling interests in acquired business 1,312,501 1,712,935
Acquired business earnout contracts and payable 3,016,667
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Interest 298,150 47,052
Income taxes 1,092,679 2,827,000
Delphax [Member]    
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from line of credit 5,387,338 1,832,600
Payments on line of credit (7,251,473) (2,827,609)
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR [1] 249,528  
CASH AND CASH EQUIVALENTS AT END OF YEAR [1] $ 328,327 $ 249,528
[1] Amounts related to Delphax as of March 31, 2017 and 2016, respectively.